Update on duloxetine for the management of stress urinary incontinence

Maya Basu, Jonathan RA DuckettDepartment of Obstetrics and Gynaecology, Medway Maritime Hospital, Gillingham, Kent, UKAbstract: Duloxetine is a relatively balanced serotonin and noradrenaline reuptake inhibitor (SNRI), which is the first drug with widely proven efficacy to have been licensed for the...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Maya Basu, Jonathan RA Duckett
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	Duloxetine stress urinary incontinence overactive bladder Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/44564db4ac3f4d029f5957081db34959
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:44564db4ac3f4d029f5957081db34959
record_format	dspace
spelling	oai:doaj.org-article:44564db4ac3f4d029f5957081db349592021-12-02T00:16:25ZUpdate on duloxetine for the management of stress urinary incontinence1178-1998https://doaj.org/article/44564db4ac3f4d029f5957081db349592008-11-01T00:00:00Zhttps://www.dovepress.com/update-on-duloxetine-for-the-management-of-stress-urinary-incontinence-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Maya Basu, Jonathan RA DuckettDepartment of Obstetrics and Gynaecology, Medway Maritime Hospital, Gillingham, Kent, UKAbstract: Duloxetine is a relatively balanced serotonin and noradrenaline reuptake inhibitor (SNRI), which is the first drug with widely proven efficacy to have been licensed for the medical treatment of women with stress urinary incontinence (SUI). Despite favorable results from randomized controlled trials, surgical management continues to be the mainstay of treatment for SUI. In this review we explore the pharmacology of duloxetine in the nervous system and lower urinary tract, and the evidence for its use in the management of women with urinary incontinence.Keywords: duloxetine, stress urinary incontinence, overactive bladderMaya BasuJonathan RA DuckettDove Medical PressarticleDuloxetinestress urinary incontinenceoveractive bladderGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 4, Pp 25-30 (2008)
institution	DOAJ
collection	DOAJ
language	EN
topic	Duloxetine stress urinary incontinence overactive bladder Geriatrics RC952-954.6
spellingShingle	Duloxetine stress urinary incontinence overactive bladder Geriatrics RC952-954.6 Maya Basu Jonathan RA Duckett Update on duloxetine for the management of stress urinary incontinence
description	Maya Basu, Jonathan RA DuckettDepartment of Obstetrics and Gynaecology, Medway Maritime Hospital, Gillingham, Kent, UKAbstract: Duloxetine is a relatively balanced serotonin and noradrenaline reuptake inhibitor (SNRI), which is the first drug with widely proven efficacy to have been licensed for the medical treatment of women with stress urinary incontinence (SUI). Despite favorable results from randomized controlled trials, surgical management continues to be the mainstay of treatment for SUI. In this review we explore the pharmacology of duloxetine in the nervous system and lower urinary tract, and the evidence for its use in the management of women with urinary incontinence.Keywords: duloxetine, stress urinary incontinence, overactive bladder
format	article
author	Maya Basu Jonathan RA Duckett
author_facet	Maya Basu Jonathan RA Duckett
author_sort	Maya Basu
title	Update on duloxetine for the management of stress urinary incontinence
title_short	Update on duloxetine for the management of stress urinary incontinence
title_full	Update on duloxetine for the management of stress urinary incontinence
title_fullStr	Update on duloxetine for the management of stress urinary incontinence
title_full_unstemmed	Update on duloxetine for the management of stress urinary incontinence
title_sort	update on duloxetine for the management of stress urinary incontinence
publisher	Dove Medical Press
publishDate	2008
url	https://doaj.org/article/44564db4ac3f4d029f5957081db34959
work_keys_str_mv	AT mayabasu updateonduloxetineforthemanagementofstressurinaryincontinence AT jonathanraduckett updateonduloxetineforthemanagementofstressurinaryincontinence
_version_	1718403861530542080

Update on duloxetine for the management of stress urinary incontinence

Ejemplares similares